期刊文献+

乳腺癌MCF-7细胞系中侧群细胞分选及其生物学特性 被引量:1

Sorting of side population cells from breast cancer MCF-7 cell line and its biological characteristics
原文传递
导出
摘要 目的分离乳腺癌MCF-7细胞系中的侧群细胞(sP)并观察其生物学特性。方法利用流式细胞荧光分选法将乳腺癌MCF-7细胞系分成SP和非SP细胞两个亚群。对两个亚群细胞采用软琼脂克隆形成实验观察其增殖能力。结果MCF-7细胞株中分选出SP细胞占(6.5±0.4)%;SP细胞的体外克隆形成率为(38.5±9.4)%,高于非sP细胞的(8.4±2.6)%(t=5.34,P〈0.05)。结论乳腺癌MCF-7细胞中的SP细胞富集了乳腺癌干细胞,其增殖能力强于非SP细胞,表明SP表型的肿瘤细胞在乳腺癌的生长中具有重要的地位。 Objective To separate the side population cells (SP) from breast cancer MCF-7 cell line, and observe its biological characteristics. Methods Flow cytometry and Hoechst 33342 dye efflux assay were used to iso- late SP ceils and non-SP ceils from the MCF-7 cell line of human breast cancer. Tumorigenicity of the two snbpopula- tions was observed by a soft agar cloning method. Results The results of FACS analysis indicated that (6.5± 0.4 ) % of the MCF-7 cells were SP cells ; The vitro colony formation rate of SP cells was ( 38.5 ± 9.4) %, and higher than that of non-SP cells ( 8.4± 2.6) % ( t = 5.34, P 〈 0.05 ). Conclusion The SP ceils sorted from MCF-7 cell line enriched tumor stem cells, which exhibited high tumorigenicity. It indicated that SP cells should play a principal role in breast cancer.
出处 《中国基层医药》 CAS 2012年第13期1927-1928,共2页 Chinese Journal of Primary Medicine and Pharmacy
基金 国家中医药管理局中医肿瘤病学重点学科经费资助[国中医药发(2009)30号]
关键词 MCF-7乳腺癌细胞系 侧群细胞 增殖 MCF-7 breast cancer stem cell Side population cell Proliferation
  • 相关文献

参考文献2

二级参考文献141

  • 1Bernards R. Cancer: cues for migration. Nature 2003; 425:247-248.
  • 2Li YM, Pan Y, Wei Y, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004; 6:459-469.
  • 3Liang Z, Wu T, Lou H, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004; 64:4302-4308.
  • 4John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7:14-23.
  • 5Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002; 2:826-835.
  • 6Pratap J, Javed A, Languino LR, et al. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol2005; 25:8581-8591.
  • 7Chinni SR, Sivalogan S, Dong Z, et al. CXCL 12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.Prostate 2006; 66:32-48.
  • 8Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109:625-637.
  • 9Janowska-Wieczorek A, Marquez LA, Dobrowsky A, Ratajczak MZ, Cabuhat ML. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol 2000; 28:1274-1285.
  • 10Kollet O, Shivtiel S, Chen YQ, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003; 112:160-169.

共引文献85

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部